Skip to content

Regulatory strategy

Medical device classification: Class I, IIa, IIb and III explained

Medical device classification is the decision every other decision hangs off. It sets whether a Notified Body is involved at all, how much clinical evidence you need, what your post market obligations look like, and how long approval takes. Manufacturers usually ask us what makes a class 1 medical device or a class 2 medical device, which is the right question in the wrong language. Under the EU Medical Device Regulation (MDR) and the Medical Devices Regulations 2002 in Great Britain the labels are Class I, Class IIa, Class IIb and Class III. A Class I medical device sits at the low risk end. A Class III medical device sits at the top, and carries the heaviest evidence burden in the system.

Intended purpose decides the class, not the technology

Article 51 of the MDR divides devices into Class I, IIa, IIb and III taking account of their intended purpose and their inherent risks. The Medical Device Coordination Group puts it bluntly in its classification guidance, MDCG 2021-24 (revision 1, April 2026): it is the intended and not the accidental use of the device that determines the class.

That is why two physically similar products can land in different classes. The claim you make, the clinical decision your device informs and how long it contacts the body do more to fix your class than the materials ever will.

Qualification also comes before classification. Before a single rule is applied you have to settle what the product is: a medical device, an accessory, a component, or something outside the regulation entirely. Get that step wrong and everything after it is wrong too.

The rules that actually do the deciding

Annex VIII of the MDR holds 22 classification rules in four groups: non invasive devices (Rules 1 to 4), invasive devices (Rules 5 to 8), active devices (Rules 9 to 13), and special rules (Rules 14 to 22) covering cases such as devices with an integral medicinal substance, contraception, disinfection, nanomaterials and substance based devices.

You do not pick the rule that suits you. You apply all of them, and the strictest rule resulting in the highest classification sets your class.

Class I splits further. Under Article 52(7), a Class I device supplied sterile is classed Is, one with a measuring function Im, and a reusable surgical instrument Ir. All three still need a Notified Body, but only for that one aspect.

What changes as the class goes up

Notified Body involvement. A plain Class I device is self declared. From Is, Im and Ir upward, and for everything from Class IIa to Class III, a Notified Body assesses conformity. That single step is usually the largest change to both your timeline and your budget.

Clinical evidence. Article 61(4) requires clinical investigations for implantable and Class III devices. The exception is narrow: the device was designed by modifying a device the same manufacturer already markets, equivalence is demonstrated under Annex XIV and endorsed by the Notified Body, and the existing clinical evaluation is sufficient. Read it wider than that and you are funding a study late. Lower classes lean more heavily on clinical evaluation of existing data, which we cover in our piece on ISO 14155.

Post market surveillance. Class I manufacturers prepare a post market surveillance report under Article 85. Class IIa manufacturers prepare a Periodic Safety Update Report at least every 24 months, and Class IIb and Class III at least every 12 months. For Class III and implantable devices the PSUR goes to the Notified Body, and it will move into EUDAMED once the vigilance module becomes mandatory.

Great Britain classifies on the older rules

This one catches people out. Regulation 7 of the Medical Devices Regulations 2002 classifies general medical devices as Class I, IIa, IIb or III using the criteria in Annex IX of Directive 93/42/EEC, the old Medical Devices Directive, read with the later amending directives that moved breast implants and hip, knee and shoulder replacements into Class III. The four labels are identical to the MDR ones. The rules underneath them are not.

So the same device, with the same intended purpose, can sit in one class for Great Britain and a higher class under the MDR. If you are marking for both markets, classify twice and write down the reasoning for each. More in our UKCA update.

The misclassifications we see most

Classifying the product instead of the claim. The technical file says one thing and the website says another. Reviewers read both.

Applying one rule and stopping. Several rules often apply to the same device. The strictest wins, and a file that never mentions the others looks like it never checked.

Assuming the class carries across markets. See above. Frequently it does not.

Software. Rule 11 moved a great deal of software up the scale compared with the old directive, and software that drives another device takes that device’s class. We covered that separately in software classification.

Classifying once and never revisiting. A new indication, a new user group or a new claim can change the class of a device that has sold safely for years.

Where Worldwide Device Solutions fits

Classification is the first thing we settle on any file, because it fixes the cost of everything after it, and it is cheaper to argue about on a call than in a Notified Body review. More than 500 CE technical files built and approved. Technical file work runs through our CE and UKCA marking service. Paul Rowden offers a free twenty minute call to tell you where your device actually sits, at no cost and no obligation. If you already have it right, that is what he will say.

How we help

CE and UKCA Marking

Technical files and design dossiers built to pass. More than 500 CE technical files built and approved.

Free download

Get the 2026 to 2028 Deadline Survival Kit

A plain English map of every MDR, IVDR and EUDAMED date, and what to do before each one. Sent straight to your inbox.

No spam. Unsubscribe in one click. We never share your details.